Our results demonstrated that rhIL11 treatment significantly alleviated histological injury, collagen deposition, liver fibrosis severity, and hydroxyproline content induced by MCM7 overexpression (Figs. 8C–F and S17A–C). This evidence concerns the gene MCM7 and Hepatic fibrosis.